ArticleHaematologica2025

Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States.

Malin Hultcrantz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.